title: Maternal manifestation of Ballantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma.
abstract: Various fetal or placental disorders cause Ballantyne's (mirror) syndrome. For the first time, we report a maternal manifestation of Ballantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma (CMN). In a pregnant woman with a CMN fetus, lung edema, hypertension, hyperthyroidism, and high serum human chorionic gonadotrophin level occurred, all of which characterize maternal manifestation of Ballantyne's syndrome. The fetus and placenta were devoid of 'edema', lacking 'triple edema', and thus this condition was not diagnosed as Ballantyne's syndrome; however, we considered this condition as the maternal manifestation of Ballantyne's syndrome. We performed emergent cesarean section at 28 weeks. Delivery acutely ameliorated maternal symptoms. Tumor was resected and was confirmed as CMN. Maternal manifestations of Ballantyne's syndrome, such as lung edema and hypertension, can occur in a mother with fetal CMN even without fetal and/or placental edema. The clinical course of this patient may suggest an etiology of Ballantyne's syndrome.
authors.affiliation: Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan.
authors.forename: Hironori
authors.initials: H
authors.lastname: Takahashi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Matsubara
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kuwata
authors.forename: Akihide
authors.initials: A
authors.lastname: Ohkuchi
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Mukoda
authors.forename: Koyomi
authors.initials: K
authors.lastname: Saito
authors.forename: Rie
authors.initials: R
authors.lastname: Usui
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Suzuki
mesh_terms: D000328:Adult; D002585:Cesarean Section; D006063:Chorionic Gonadotropin / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000175:diagnosis*; D046110:Hypertension, Pregnancy-Induced / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D006980:Hyperthyroidism / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D007231:Infant, Newborn; D007680:Kidney Neoplasms / Q000150:complications / Q000175:diagnosis / Q000196:embryology* / Q000601:surgery; D018201:Nephroma, Mesoblastic / Q000150:complications / Q000175:diagnosis / Q000196:embryology* / Q000601:surgery; D011225:Pre-Eclampsia / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D011296:Prenatal Diagnosis; D011654:Pulmonary Edema / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D013577:Syndrome; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D006063:Chorionic Gonadotropin
keywords: Ballantyne's syndrome; human chorionic gonadotrophin; mesoblastic nephroma; mirror syndrome; pre-eclampsia